Skip to main content
Douglas Krakower, MD, Infectious Disease, Boston, MA

Douglas Scott Krakower MD

HIV/AIDS Medicine, STD Medicine, Clinical Informatics


Faculty, Beth Israel Deaconess Medical Center, Harvard Medical School

Join to View Full Profile
  • 110 Francis St Ste GbBeth Israel Deaconess Medical CenterBoston, MA 02215

  • Phone+1 617-632-0760

  • Fax+1 617-632-7626

Dr. Krakower is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 2009 - 2012
  • Mass General Brigham/Massachusetts General Hospital/Harvard Medical School
    Mass General Brigham/Massachusetts General Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 2004 - 2008
  • Harvard Medical School
    Harvard Medical SchoolClass of 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2007 - 2026
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Public Health Detailing for HIV Pre-Exposure Prophylaxis  
    Alex S Keuroghlian, Douglas S Krakower, Demetre Daskalakis, Clinical Infectious Diseases

Lectures

  • Will the Newest Pill for HIV Prevention Fuel Progress — or Profits? 
    Beth Israel Deaconess Hospital - Needham , Harvard Medical School ,Department Of Continuing Educatio - 5/30/2013

Press Mentions

  • BIDMC Investigators and Mass General Brigham Colleagues Join Nationwide Effort to Study the Spread of Respiratory Viruses
    BIDMC Investigators and Mass General Brigham Colleagues Join Nationwide Effort to Study the Spread of Respiratory VirusesJanuary 8th, 2025
  • Are We Getting the Most Out of HIV Post-Exposure Prophylaxis?
    Are We Getting the Most Out of HIV Post-Exposure Prophylaxis?November 25th, 2024
  • A Little Blue Pill That Protects You from HIV — if You Use It
    A Little Blue Pill That Protects You from HIV — if You Use ItJanuary 29th, 2021
  • Join now to see all

Grant Support

  • Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing in Community Health Centers (PrEDICT)HARVARD PILGRIM HEALTH CARE, INC.2023–2028
  • Hybrid implementation-effectiveness study to optimize HIV testing and PrEP in a southern jail (HOTSPOT)UT SOUTHWESTERN MEDICAL CENTER2022–2027
  • Hybrid implementation-effectiveness study to optimize HIV testing and PrEP in a southern jail (HOTSPOT)UT SOUTHWESTERN MEDICAL CENTER2022–2027
  • Trends in Incidence and Prevalence of HIV Diagnoses in a Jail Population in the Southern United StatesUT SOUTHWESTERN MEDICAL CENTER2022–2027
  • Over-the-Counter PrEP: Acceptability, Feasibility, and Potential Impact of Access without a Prescription (OFFSCRIPT)HARVARD PILGRIM HEALTH CARE, INC.2024–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: